Ipilimumab-induced enteritis without colitis: A new challenge

Case Reports in Oncology

Volumn 9, Issue 3, 2016, Pages 705-713

  Messmer, Marcus ^a   Upreti, Sunita ^b   Tarabishy, Yaman ^a   Mazumder, Nikhilesh ^a   Chowdhury, Reezwana ^a   Yarchoan, Mark ^c   Holdhoff, Matthias ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Colitis; CTLA4 inhibitor; Enteritis; Immunotherapy; Ipilimumab; Melanoma

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; IPILIMUMAB; LACTOFERRIN; METHYLPREDNISOLONE; METRONIDAZOLE; PEMBROLIZUMAB; PREDNISONE;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; AGED; ARTICLE; BACTERIUM CULTURE; BLOODY DIARRHEA; CASE REPORT; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOSPORIDIUM; DRUG DOSE INCREASE; DUODENUM BIOPSY; ELECTROLYTE DISTURBANCE; ENTERITIS; FATIGUE; GIARDIA; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOTENSION; INFLAMMATION; INTESTINE ENDOSCOPY; LEUKOCYTE COUNT; MALE; METABOLIC ACIDOSIS; METASTATIC MELANOMA; MICROSPORIDIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGMOIDOSCOPY; VERY ELDERLY;

EID: 84994691339     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000452403     Document Type: Article

References (7)

1. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363: 711-723.
2. Pages C, Gornet JM, Monsel G, et al. Ipilimumab-induced acute severe colitis treated by infliximab. Melanoma Res 2013;23: 227-230.
3. Wolchok JD, Kluger H, Callahan MK, et al. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med 2013;369: 122-133.
4. Robert C, Schachter J, Long GV, et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med 2015;372: 2521-2532.
5. Quirk SK, Shure AK, Agrawal DK, et al. Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma. Transl Res 2015;166: 412-424.
6. Ipilimumab (package insert). Bristol-Myers Squibb Company. Princeton, 2011.
7. Fecher LA, Agrawala SS, Hodi FS, et al. Ipilimumab and its toxicities: A multidisciplinary approach. Oncologist 2013; 18: 733-743.